SEC 13F Intelligence

Handelsbanken Fonder AB / BSX

Handelsbanken Fonder AB’s Boston Scientific Corp Position

Does Handelsbanken Fonder AB own Boston Scientific Corp (BSX)? Yes — 2.59M shares worth $162M (+0.54% of its 13F portfolio) as of Q1 2026, up from 2.52M shares the prior filed quarter.

Position Value
$162M
Q1 2026
Shares
2.59M
% of Portfolio
+0.54%
Quarters Held
24
currently held

Position History BSX

Reported value by quarter
Q2 ’20: $22MQ2 ’20Q3 ’20: $13MQ4 ’20: $12MQ1 ’21: $14MQ1 ’21Q2 ’21: $17MQ3 ’21: $18MQ4 ’21: $17MQ4 ’21Q1 ’22: $17MQ2 ’22: $16MQ3 ’22: $16MQ3 ’22Q4 ’22: $23MQ1 ’23: $25MQ2 ’23: $29MQ2 ’23Q3 ’23: $29MQ4 ’23: $34MQ1 ’24: $83MQ1 ’24Q2 ’24: $108MQ3 ’24: $199MQ4 ’24: $228MQ4 ’24Q1 ’25: $269MQ2 ’25: $256MQ3 ’25: $220MQ3 ’25Q4 ’25: $240MQ1 ’26: $162Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.59M$162M+0.54%
Q4 20252.52M$240M+0.73%
Q3 20252.26M$220M+0.70%
Q2 20252.38M$256M+0.91%
Q1 20252.66M$269M+1.11%
Q4 20242.56M$228M+0.87%
Q3 20242.37M$199M+0.79%
Q2 20241.41M$108M+0.47%
Q1 20241.22M$83M+0.36%
Q4 2023584.8K$34M+0.16%
Q3 2023548.8K$29M+0.16%
Q2 2023543.9K$29M+0.16%
Q1 2023504.5K$25M+0.15%
Q4 2022489.1K$23M+0.14%
Q3 2022424.9K$16M+0.11%
Q2 2022421.3K$16M+0.10%
Q1 2022394.4K$17M+0.10%
Q4 2021406.7K$17M+0.09%
Q3 2021414.4K$18M+0.09%
Q2 2021401.6K$17M+0.09%
Q1 2021355.9K$14M+0.08%
Q4 2020343.8K$12M+0.08%
Q3 2020340.2K$13M+0.10%
Q2 2020622.7K$22M+0.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Handelsbanken Fonder AB’s full portfolio or all institutional holders of BSX.